Skip to main content
Figure 4 | BMC Palliative Care

Figure 4

From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain

Figure 4

Mean Brief Pain Inventory (BPI) interference scores at baseline, end of immediate-release (IR) phase, and end of sustained-release (SR) phase. Values at baseline represent means; values at other time points represent least-squares means. At baseline: hydromorphone, n = 99; morphine, n = 101. In IR phase: IR hydromorphone, n = 99; IR morphine, n = 101. In SR phase: OROS® hydromorphone, n = 77; controlled-release (CR) morphine, n = 86.

Back to article page